SEC Tracker
Get the app

Revolution Medicines RVMD

Todd Cislini Jeffrey (Officer) plans to sell 75,894 RVMD shares, about $16.1M

Form
144
Filed
Importance
Routine
  1. Approximate sale date: Aug 21, 2026
  2. Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
  3. Shares acquired by: Restricted Stock Units; Exercise of Stock Options
  4. 10b5-1 plan adopted: May 22, 2026

All of Todd Cislini Jeffrey's insider filings, holdings and planned sales

Form 4s that likely executed this notice (SEC Tracker's match by person, company, dates and shares):

  • Sold 3,400 shares at $207.24 on Aug 21, 2026 · Form 4
  • Sold 17,323 shares at $208.37 on Aug 21, 2026 · Form 4
  • Sold 25,817 shares at $209.25 on Aug 21, 2026 · Form 4
  • Sold 2,540 shares at $210.26 on Aug 21, 2026 · Form 4
  • Sold 4,500 shares at $211.34 on Aug 21, 2026 · Form 4
  • Sold 3,314 shares at $212.06 on Aug 21, 2026 · Form 4
  • Sold 52 shares at $195.01 on Sep 16, 2026 · Form 4
  • Sold 3,314 shares at $199.3 on Sep 16, 2026 · Form 4
  • Sold 765 shares at $207.32 on Sep 25, 2026 · Form 4

Written from the Form 144 on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Revolution Medicines files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. Biomarin Pharmaceutical BMRN public float $6.7B, Jun 30, 2025
  2. Jazz Pharmaceuticals JAZZ public float $6.3B, Jun 30, 2025
  3. Corcept Therapeutics CORT public float $6.1B, Jun 30, 2025
  4. Repligen RGEN public float $6.0B, Jun 30, 2025
  5. Madrigal Pharmaceuticals MDGL public float $5.6B, Jun 30, 2025